Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Aponte

Showing results (131-140 of 181) with videos related to

Pageof 19
Sort By:
Immunobiology|January 25, 2011
IgG against Plasmodium falciparum variant surface antigens and growth inhibitory antibodies in Mozambican children receiving intermittent preventive treatment with sulfadoxine-pyrimethamineDiana Quelhas, Alfons Jiménez, Llorenç Quintó, et al.
Plos Medicine|April 6, 2012
Intermittent preventive treatment for malaria in Papua New Guinean infants exposed to Plasmodium falciparum and P. vivax: a randomized controlled trialNicolas Senn, Patricia Rarau, Danielle I Stanisic, et al.
Frontiers in Immunology|September 8, 2017
RTS,S/AS01E Malaria Vaccine Induces Memory and Polyfunctional T Cell Responses in a Pediatric African Phase III TrialGemma Moncunill, Stephen C De Rosa, Aintzane Ayestaran, et al.
Clinical and Vaccine Immunology : CVI|December 16, 2011
Age-dependent IgG subclass responses to Plasmodium falciparum EBA-175 are differentially associated with incidence of malaria in Mozambican childrenCarlota Dobaño, Diana Quelhas, Llorenç Quintó, et al.
Lancet (London, England)|December 13, 2005
Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trialPedro L Alonso, Jahit Sacarlal, John J Aponte, et al.
Plos Medicine|February 25, 2016
Mortality, Morbidity, and Developmental Outcomes in Infants Born to Women Who Received Either Mefloquine or Sulfadoxine-Pyrimethamine as Intermittent Preventive Treatment of Malaria in Pregnancy: A Cohort StudyMaría Rupérez, Raquel González, Ghyslain Mombo-Ngoma, et al.
Plos Medicine|September 2, 2022
Burden of malaria in pregnancy among adolescent girls compared to adult women in 5 sub-Saharan African countries: A secondary individual participant data meta-analysis of 2 clinical trialsClara Pons-Duran, Ghyslain Mombo-Ngoma, Eusebio Macete, et al.
Malaria Journal|July 2, 2025
Assessing the accuracy of the recording and reporting of malaria rapid diagnostic test results in four African countries: methods and key resultsKim A Lindblade, Arthur Mpimbaza, Corine Ngufor, et al.
Plos Medicine|September 14, 2012
Reduced risk of Plasmodium vivax malaria in Papua New Guinean children with Southeast Asian ovalocytosis in two cohorts and a case-control studyAnna Rosanas-Urgell, Enmoore Lin, Laurens Manning, et al.
Trials|March 28, 2007
Evaluation of two formulations of adjuvanted RTS, S malaria vaccine in children aged 3 to 5 years living in a malaria-endemic region of Mozambique: a Phase I/IIb randomized double-blind bridging trialEusebio V Macete, Jahit Sacarlal, John J Aponte, et al.
Pageof 19

Showing results (131-140 of 181) with videos related to

Sort By:
Pageof 19
Immunobiology|January 25, 2011
IgG against Plasmodium falciparum variant surface antigens and growth inhibitory antibodies in Mozambican children receiving intermittent preventive treatment with sulfadoxine-pyrimethamineDiana Quelhas, Alfons Jiménez, Llorenç Quintó, et al.
Plos Medicine|April 6, 2012
Intermittent preventive treatment for malaria in Papua New Guinean infants exposed to Plasmodium falciparum and P. vivax: a randomized controlled trialNicolas Senn, Patricia Rarau, Danielle I Stanisic, et al.
Frontiers in Immunology|September 8, 2017
RTS,S/AS01E Malaria Vaccine Induces Memory and Polyfunctional T Cell Responses in a Pediatric African Phase III TrialGemma Moncunill, Stephen C De Rosa, Aintzane Ayestaran, et al.
Clinical and Vaccine Immunology : CVI|December 16, 2011
Age-dependent IgG subclass responses to Plasmodium falciparum EBA-175 are differentially associated with incidence of malaria in Mozambican childrenCarlota Dobaño, Diana Quelhas, Llorenç Quintó, et al.
Lancet (London, England)|December 13, 2005
Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trialPedro L Alonso, Jahit Sacarlal, John J Aponte, et al.
Plos Medicine|February 25, 2016
Mortality, Morbidity, and Developmental Outcomes in Infants Born to Women Who Received Either Mefloquine or Sulfadoxine-Pyrimethamine as Intermittent Preventive Treatment of Malaria in Pregnancy: A Cohort StudyMaría Rupérez, Raquel González, Ghyslain Mombo-Ngoma, et al.
Plos Medicine|September 2, 2022
Burden of malaria in pregnancy among adolescent girls compared to adult women in 5 sub-Saharan African countries: A secondary individual participant data meta-analysis of 2 clinical trialsClara Pons-Duran, Ghyslain Mombo-Ngoma, Eusebio Macete, et al.
Malaria Journal|July 2, 2025
Assessing the accuracy of the recording and reporting of malaria rapid diagnostic test results in four African countries: methods and key resultsKim A Lindblade, Arthur Mpimbaza, Corine Ngufor, et al.
Plos Medicine|September 14, 2012
Reduced risk of Plasmodium vivax malaria in Papua New Guinean children with Southeast Asian ovalocytosis in two cohorts and a case-control studyAnna Rosanas-Urgell, Enmoore Lin, Laurens Manning, et al.
Trials|March 28, 2007
Evaluation of two formulations of adjuvanted RTS, S malaria vaccine in children aged 3 to 5 years living in a malaria-endemic region of Mozambique: a Phase I/IIb randomized double-blind bridging trialEusebio V Macete, Jahit Sacarlal, John J Aponte, et al.
Pageof 19